Company intelligence / Profile preview

Cura-Can Health

Canada

Ownership: Private
Development stage: Other

Overview

Cura-Can Health Corp was a private Canadian company focused on developing and commercializing cannabidiol (CBD) medicinal and wellness products for distribution within Canada and other approved jurisdictions. It operated commercially rather than as a clinical-stage drug developer, and entered receivership in early 2022.[2][5]

Therapeutic areas: NeurologyOther
Modalities: Small moleculeNatural productCannabinoid
Industry: Biotech

Beyond the preview

Go deeper on Cura-Can Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cura-Can Health.

Explore the full profile